BioMotiv is developing a portfolio of novel therapeutics based on technologies licensed from research institutions and industry sources.
BioMotiv is a therapeutic accelerator developing a portfolio of new medicines. We are interested in all disease areas and types of therapeutics. Innovators can submit technologies for consideration here.
The company is interested in all disease areas and types of therapeutics—small molecules, antibodies, proteins, cell therapies, and nucleotides. BioMotiv is sourcing products from the discovery to pre-clinical stages of development, and also consider drug repurposing opportunities.
Click to view more